Chemical Structure : MRIA9
CAS No.: 2750707-05-0
货号: PC-72723Not For Human Use, Lab Use Only.
MRIA9 is a potent, selective dual SIK/PAK inhibitor, inhibits SIK1/2/3 with cellular IC50 of 586/180/127 nM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥1880 | In stock | |
5 mg | ¥2980 | In stock | |
10 mg | ¥4580 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MRIA9 is a potent, selective dual SIK/PAK inhibitor, inhibits SIK1/2/3 with cellular IC50 of 586/180/127 nM, respectively.
MRIA9 displays excellent selectivity in scanMAX kinase assay panel of 468 kinases.
MRIA9 sensitizes ovarian cancer cells to treatment with the mitotic agent paclitaxel.
MRIA9-induced inhibition of SIK2 blocks the centrosome disjunction, impairs the centrosome alignment, and causes spindle mispositioning during mitosis.
MRIA9 increases chromosomal instability in ovarian cancer cell lines.
分子量 | 495.939 | |
分子式 | C25H23ClFN5O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-3-(2-chloro-4-(3-fluoropyridin-2-yl)phenyl)-7-(methylamino)-1,6-naphthyridin-2(1H)-one |
1. Tesch R, et al. J Med Chem. 2021 Jun 24;64(12):8142-8160.
2. Raab M, et al. Cancers (Basel). 2021 Jul 21;13(15):3658.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright